Panaxia Labs Israel Ltd
Panaxia Pharmaceutical Industries Ltd provides pharmaceutical solutions for patients and physicians. The company offers pharma-grade smokeless cannabis products, such as oral and sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches. Panaxia Pharmaceutical Industries Ltd has strategic partnerships with Ultra Health,… Read more
Panaxia Labs Israel Ltd (HROD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2019: 0.052x
Based on the latest financial reports, Panaxia Labs Israel Ltd (HROD) has a cash flow conversion efficiency ratio of 0.052x as of June 2019.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.07 Million) by net assets (ILA-20.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Panaxia Labs Israel Ltd - Cash Flow Conversion Efficiency Trend (2015–2018)
This chart illustrates how Panaxia Labs Israel Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Panaxia Labs Israel Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Panaxia Labs Israel Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
K-W
NYSE:K-W
|
N/A |
|
TRIPADVISOR
BE:T6A
|
-0.046x |
|
Kalium Lakes Ltd
AU:KLL
|
0.761x |
|
Chrometco Ltd
JSE:CMO
|
-0.213x |
|
TRACON Pharmaceuticals Inc
OTCQB:TCON
|
0.896x |
|
VILKYSKIU PIENINE (UDW.SG)
STU:UDW
|
0.103x |
|
Centrais Electricas Brasileiras S.A.- Eletrobr?!s American Depositary Shares (Each representing one Preferred Share)
NYSE:EBRB
|
-0.002x |
|
FRBP
PINK:FRBP
|
0.008x |
Annual Cash Flow Conversion Efficiency for Panaxia Labs Israel Ltd (2015–2018)
The table below shows the annual cash flow conversion efficiency of Panaxia Labs Israel Ltd from 2015 to 2018.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2018-12-31 | ILA11.66 Million | ILA-1.70 Million | -0.146x | +11.08% |
| 2017-12-31 | ILA9.04 Million | ILA-1.48 Million | -0.164x | -177.79% |
| 2016-12-31 | ILA12.92 Million | ILA-761.00K | -0.059x | +69.28% |
| 2015-12-31 | ILA17.57 Million | ILA-3.37 Million | -0.192x | -- |